Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients

European Journal of Clinical Investigation

Volumn 39, Issue 12, 2009, Pages 1091-1097

  Scarpato, R ^a   Tusa, I ^a   Antonelli, A ^a   Fallhai, P ^a   Sbrana, I ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Chromosome damage; Micronuclei; Peripheral lymphocytes; Thyroiditis

Indexed keywords

BLEOMYCIN; IODINE 131; LIOTHYRONINE; THYROXINE;

ADULT; ARTICLE; CHROMOSOME DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; PRIORITY JOURNAL; SIDE EFFECT; THYROID DISEASE; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CHROMOSOMES, HUMAN; DNA DAMAGE; DNA, NEOPLASM; FEMALE; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; THYROID GLAND; THYROIDITIS;

EID: 70449461349     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02214.x     Document Type: Article

References (44)

1. Anderson MS. Update in endocrine autoimmunity. J Clin Endocrinol Metab 2008 93 : 3663 3670.
2. Migliore L, Bevilacqua C, Scarpato R. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus (SLE) and systemic sclerosis (SS) patients. Mutagenesis 1999 14 : 227 231.
3. Porciello G, Scarpato R, Ferri C, Storino F, Cagetti F, Morozzi G et al. Spontaneus chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 2003 30 : 1244 1247.
4. Holland N, Harmatz P, Golden D, Hubbard A, Wu YY, Bae J et al. Cytogenetic damage in blood lymphocytes and exfoliated epithelial cells of children with inflammatory bowel disease. Paediatric Res 2007 61 : 209 214.
5. Martínez-Pérez LM, Cerda-Flores RM, Gallegos-Cabriales EC, Dávila-Rodríguez MI, Ibarra-Costilla E, Cortés- Gutiérrez EI. Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. Prague Med Rep 2007 108 : 248 255.
6. Moran LJ, Noakes M, Clifton PM, Norman RJ, Fenech MF. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res 2008 639 : 55 63.
7. Bonassi S, Znaror A, Ceppi M, Lando C, Chang WP, Holland N et al. An increased micronucleus frequency in pheripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007 28 : 625 631.
8. Au WW. Mutagen sensitivity assays in population studies. Mutat Res 2003 544 : 273 277.
9. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007 67 : 3493 3495.
10. Lin J, Zhang X, Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis. Hum Reprod 2003 18 : 2052 2057.
11. Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA et al. Mutagen sensitivity and neoplastic progression in patients with Barrett's oesophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev 2006 15 : 1935 1940.
12. Gutiérrez S, Carbonell E, Galofré P, Creus A, Marcos R. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test. Eur J Nucl Med 1999 26 : 1589 1596.
13. Dardano A, Ballardin M, Ferdeghini M, Lazzeri E, Traino C, Caraccio N et al. Anticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy. J Clin Endocrinol Metab 2007 92 : 4286 4289.
14. Scarpato R, Migliore L, Angotzi G, Fedi A, Miligi L, Loprieno N. Cytogenetic monitoring of a group of Italian floriculturists: no evidence of DNA damage related to pesticide exposure. Mutat Res 1996 367 : 73 82.
15. Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus project- an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 1999 428 : 271 283.
16. Sbrana I, Veroni F, Nieri M, Puliti A, Barale R. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer. Genes Chromosomes Cancer 2006 45 : 429 436.
17. Wuttke K, Streffer C, Müller WU, Reiners C, Biko J, Demidchik E. Micronuclei in lymphocytes of children from the vicinity of Chernobyl before and after 131I therapy for thyroid cancer. Int J Radiat Biol 1996 69 : 259 268.
18. 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis. Eur J Nucl Med Mol Imaging 2008 35 : 2113 2121.
19. Scarpato R, Antonelli A, Ballardin M, Cipollini M, Fallahi P, Tomei A et al. Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules. Mutat Res 2006 606 : 21 6.
20. Wolff DJ, Needleman BW, Wasserman SS, Schwartz S. Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 1991 18 : 837 840.
21. Emerit I, Filipe P, Meunier P, Auclair C, Freitas J, Deroussent A et al. Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress. Dermatology 1997 194 : 140 146.
22. Andreassi MG, Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 2003 13 : 270 275.
23. Ulker OC, Ustundag A, Duydu Y, Yucesoy B, Karakaya A. Cytogenetic monitoring of coal workers and patients with coal workers' pneumoconiosis in Turkey. Environ Mol Mutagen 2008 49 : 232 237.
24. Sarandöl E, Taş S, Dirican M, Serdar Z. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 2005 23 : 1 8.
25. Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 2007 115 : 522 526. (Pubitemid 350056765)
26. Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B et al. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med 2008 46 : 1004 1010.
27. Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun Rev 2008 7 : 530 537.
28. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol 2009 70 : 469 474.
29. Aniello F, Couchie D, Gripois D, Nunez J. Regulation of five tubulin isotypes by thyroid hormone during brain development. J Neurochem 1991 57 : 1781 1786.
30. Singh R, Upadhyay G, Kumar S, Kapoor A, Kumar A, Tiwari M et al. Hypothyroidism alters the expression of Bcl-2 family genes to induce enhanced apoptosis in the developing cerebellum. J Endocrinol 2003 176 : 39 46.
31. Migliore L, Scarpato R, Coppede F, Petrozzi L, Bonuccelli U, Rodilla V. Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients. Int J Hyg Environ Health 2001 204 : 61 6.
32. Blandini F, Cosentino M, Mangiagalli A, Marino F, Samuele A, Rasini E et al. Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment. J Neural Transm 2004 111 : 1017 1030.
33. Hoelzl C, Bichler J, Ferk F, Simic T, Nersesyan A, Elbling L et al. Methods for the detection of antioxidants which prevent age related diseases: a critical review with particular emphasis on human intervention studies. J Physiol Pharmacol 2005 56 : 49 64.
34. Pernice F, Floccari F, Caccamo C, Belghity N, Mantuano S, Pacilè ME et al. Chromosomal damage and atherosclerosis. A protective effect from simvastatin. Eur J Pharmacol 2006 532 : 223 229.
35. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002 23 : 1003 1008.
36. Angelini S, Kumar R, Carbone F, Bermejo JL, Maffei F, Cantelli-Forti G et al. Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity. Mutat Res 2008 638 : 90 9.
37. Cloos J, de Bor W, Snel M, van de Ijssel P, Yistra B, Leemans R et al. Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes. Mol Cancer Res 2006 4 : 71 7.
38. Turken O, Yavuz Narin Y, Demirbas S, Onde ME, Sayan O, Kandemir EG et al. Breast cancer in association with thyroid disorders. Breast Cancer Res 2003 5 : R110 3.
39. Perillat-Menegaux F, Clavel J, Auclerc MF, Baruchel A, Leverger G, Nelken B et al. Family history of autoimmune thyroid disease and childhood acute leukaemia. Cancer Epidemiol Biomarkers Prev 2003 12 : 60 3.
40. Dalamaga M, Karmaniolas K, Papadavid E, Pelecanos N, Migdalis I. Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: a case-control study. Leuk Lymphoma 2008 49 : 1545 1552.
41. Harach HR, Ceballos GA. Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model. Endocr Pathol 2008 19 : 209 220.
42. Dietl J, Engel JB, Wischhusen J. The role of regulatory T cells in ovarian cancer. Int J Gynecol Cancer 2007 17 : 764 770.
43. Toubi E, Shoenfeld Y. Protective autoimmunity in cancer. Oncol Rep 2007 17 : 245 251.
44. Beyer M, Schultze JL. Immunoregulatory T cells: role and potential as a target in malignancy. Curr Oncol Rep 2008 10 : 130 136.